Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e0905262f429c7590b40df8448c0c5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
2014-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f787ce0ec22da779abee8163289eea0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cb13d4bc0f58f74d069154ad4bc1fda http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af5ce144e4faeb67b8726b99ed2718ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2111cadf6e48f81fa96e0efabcc72bd7 |
publicationDate |
2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2015091352-A1 |
titleOfInvention |
Tamper resistant dosage form with bimodal release profile manufactured by co-extrusion |
abstract |
11GRA3639-WO/JBdk Summary: The invention relates toa monolithic pharmaceutical dosage form comprising a hot melt-extruded first segment (S ) and a second segment (S 2 ); whereinthe first segment (S ) contains at least a first pharmacologically active ingredient (A ) and/or the second segment (S 2 )contains at least a second pharmacologically active ingredient (A 2 ); andthe segment (S ) and/or the segment (S 2 ) is tamper-resistantand/orexhibits a breaking strength of at least 300N. |
priorityDate |
2013-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |